Search results
FDA approves Eli Lilly’s Kisunla (donanemab) for early AD
Pharmaceutical Technology· 6 days agoEli Lilly announced on 2 July 2024 that the US Food and Drug Administration (FDA) has approved its...
CEPI announces plans for Nipah virus antibody trials
Clinical Trials Arena· 5 days agoThe Coalition for Epidemic Preparedness Innovations (CEPI) has announced plans to commence clinical trials to evaluate MBP1F5, a monoclonal antibody (mAb...
EAN 2024: The role of B cells in shaping rituximab use in generalised MG
Clinical Trials Arena· 5 days agoGiven the negative side-effect profiles of the aforementioned therapies and the fact that they do...
Nipah monoclonal antibody to undergo human trials in India, Bangladesh in 2025
IBTmes India· 6 days agoNipah virus, a zoonotic disease of the Paramyxovirus family, kills up to 75 per cent of the people...
EAN 2024: Benefits of early migraine treatment clear but implementation remains challenging
Clinical Trials Arena· 6 days agoA further key challenge highlighted during the symposium is that due to the variability of migraine...
Dr Reddys Labs Summary: Latest Updates and Details | India Infoline
India Infoline· 2 days agoDr Reddys Laboratories Ltd (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses ...